Joint swelling: FDA reporting patterns
118,884 FDA FAERS reports mention Joint swelling. 68,744 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 25,128 reports
- Adalimumab: 22,388 reports
- Abatacept: 19,811 reports
- Methotrexate: 18,267 reports
- Tocilizumab: 15,511 reports
- Leflunomide: 13,559 reports
- Rituximab: 11,972 reports
- Hydroxychloroquine: 11,839 reports
- Tofacitinib: 11,143 reports
- Infliximab: 11,060 reports
- Sulfasalazine: 10,020 reports
- Certolizumab Pegol: 9,069 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.